NLRP3 is context-dependent longevity-positive, not yet a universal bottleneck

NLRP3 is a context-dependent longevity-positive node, but not yet a universal immune/炎症长寿瓶颈

''结论'': NLRP3 inflammasome suppression can be longevity-positive in mice, but the present evidence still falls short of elevating it to a universal immune/炎症长寿瓶颈.

''关键证据'':
# PMID 31625260 / Aging Cell 2020: NLRP3 ablation in mice reported protection from age-related cardiac decline, improved metabolic/autophagy/NAD-related readouts, and increased lifespan in the studied cohort.
# 女性/器官特异证据 mainly supports tissue aging modulation rather than system-level longevity: e.g. ovarian aging, cognitive/metaflammation, adipose immune aging.

''判定'':
# A single lifespan-positive mouse context is not enough to upgrade an inflammatory axis to a universal bottleneck.
# To promote NLRP3 above other immune candidates, we would still need cross-sex reproduction, broader multi-organ healthspan, and head-to-head comparison against more upstream immune-entry points.
# Practically, NLRP3 should be treated as a promising context-dependent inflammatory lever, not as the default top-tier immune bottleneck.

''可复用判断'':
# If an inflammasome node shows one sex- or organ-limited lifespan positive but the rest of the evidence is tissue-specific aging modulation, classify it as context-dependent longevity-positive rather than universal longevity bottleneck.
# Promotion requires: lifespan/healthspan beyond one organ, sex robustness, and superiority over upstream inflammatory loops (e.g. IL-1 / emergency myelopoiesis).